Company Filing History:
1 out of 2 
1 out of 5 Years Active: 2006
Title: Shigehide Kagaya: Innovator in Cancer Research
Introduction
Shigehide Kagaya is a notable inventor based in Omiya, Japan. He has made significant contributions to the field of cancer research through his innovative work on gene encoding and tumor suppressor genes. His research focuses on understanding and treating diseases caused by abnormal cell propagation.
Latest Patents
Kagaya holds a patent for a gene encoding the promoter domain of the tumor suppressor gene P51. This invention provides a gene capable of inducing cell death, which is crucial in diagnosing and treating various diseases, including cancer. The patent also includes antisense DNAs and RNAs, nucleic acid probes, and methods for detecting these genes, which are essential for drug screening and therapeutic applications.
Career Highlights
Throughout his career, Shigehide Kagaya has worked with prominent companies in the biotechnology sector, including Toshiyuki Sakai and Oncolys Biopharma, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research on cancer treatment.
Collaborations
Kagaya has collaborated with notable individuals such as Toshiyuki Sakai and Takamichi Sato. These partnerships have enhanced his research efforts and contributed to advancements in cancer diagnostics and therapeutics.
Conclusion
Shigehide Kagaya's work in gene encoding and tumor suppressor research has the potential to significantly impact cancer treatment and diagnostics. His innovative contributions continue to pave the way for advancements in medical science.